A short term open clinical trial of clobazam in the treatment of patients with panic attacks.
Judd F K, Burrows G D, Marriott P F, +1 more·International clinical psychopharmacology
Clobazam, a 1-5 benzodiazepine with anxiolytic properties, was evaluated in the treatment of patients with DSM-III panic disorder or agoraphobia with panic attacks. In this open clinical trial, 10 of the 15 patients completed 8 weeks of treatment. Six of the 10 completers (60%) were responders (75% reduction in the num…